GURUFOCUS.COM » STOCK LIST » Technology » Software » UiPath Inc (NYSE:PATH) » Definitions » Cash, Cash Equivalents, Marketable Securities

UiPath (UiPath) Cash, Cash Equivalents, Marketable Securities : $1,880 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is UiPath Cash, Cash Equivalents, Marketable Securities?

UiPath's quarterly cash, cash equivalents, marketable securities declined from Jul. 2023 ($1,829.57 Mil) to Oct. 2023 ($1,817.18 Mil) but then increased from Oct. 2023 ($1,817.18 Mil) to Jan. 2024 ($1,879.82 Mil).

UiPath's annual cash, cash equivalents, marketable securities declined from Jan. 2022 ($1,865.14 Mil) to Jan. 2023 ($1,756.89 Mil) but then increased from Jan. 2023 ($1,756.89 Mil) to Jan. 2024 ($1,879.82 Mil).


UiPath Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for UiPath's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UiPath Cash, Cash Equivalents, Marketable Securities Chart

UiPath Annual Data
Trend Jan20 Jan21 Jan22 Jan23 Jan24
Cash, Cash Equivalents, Marketable Securities
232.39 460.52 1,865.14 1,756.89 1,879.82

UiPath Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,756.89 1,780.65 1,829.57 1,817.18 1,879.82

UiPath Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


UiPath  (NYSE:PATH) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


UiPath Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of UiPath's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


UiPath (UiPath) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » UiPath Inc (NYSE:PATH) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
One Vanderbilt Avenue, 60th Floor, New York, NY, USA, 10017
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of its revenues from the US, followed by Romania.
Executives
Ashim Gupta officer: Chief Financial Officer C/O UIPATH, INC., ONE VANDERBILT AVENUE, 60TH FLOOR, NEW YORK NY 10017
Rich Wong director, 10 percent owner 428 UNIVERSITY AVE, PALO ALTO CA 94555
Brad Brubaker officer: GC & Chief Legal Officer C/O UIPATH, INC., ONE VANDERBILT AVENUE, 60TH FLOOR, NEW YORK NY 10017
Hitesh Ramani officer: Chief Accounting Officer C/O UIPATH, INC., ONE VANDERBILT AVENUE, 60TH FLOOR, NEW YORK NY 10017
Karenann K Terrell director C/O PLURALSIGHT, INC., 182 NORTH UNION AVENUE, FARMINGTON UT 84025
Kimberly Hammonds director 100 EAST DAVIE STREET, RALEIGH NC 27601
Robert Enslin officer: co-Chief Executive Officer C/O UIPATH, INC., ONE VANDERBILT AVENUE, 60TH FLOOR, NEW YORK NY 10017
Christopher Lee Weber officer: Chief Business Officer C/O UIPATH, INC., 452 5TH AVENUE, 22ND FLOOR, NEW YORK NY 10018
Ted Kummert officer: EVP, Product & Engineering C/O UIPATH, INC., 452 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10018
Daniel Dines director, 10 percent owner, officer: CEO and Chairman C/O UIPATH, INC., 452 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10018
Thomas Neergaard Hansen officer: Chief Revenue Officer C/O UIPATH, INC., 452 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10018
Philippe Botteri director, 10 percent owner 500 UNIVERSITY AVENUE, PALO ALTO CA 94301
Carl M. Eschenbach director C/O SEQUOIA CAPITAL, 2800 SAND HILL ROAD, SUITE 101, PALO ALTO CA 94025
Thomas F Mendoza director 495 E. JAVA DRIVE, SUNNYVALE CA 94089
Accel Growth Fund Iv Strategic Partners L.p. 10 percent owner 428 UNIVERSITY AVENUE, PALO ALTO CA 94301

UiPath (UiPath) Headlines

From GuruFocus